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Abstract
Coeliac disease (CD) is a chronic autoimmune inflammatory condition of the small bowel; the only 
treatment is lifelong adherence to a gluten free diet (GFD). Adherence to a GFD also minimises the 
risk of associated conditions such as osteoporosis in CD patients. The present study aimed to 
evaluate and optimise management of bone disease in CD patients in a dietetic-led clinic.
This study was conducted in two parts: study 1 utilised retrospective data to evaluate management of 
bone disease with reference to British Society of Gastroenterology (BSG) guidelines in 229 CD 
patients. Based on the results from study 1, study 2 developed a tool to estimate dietary calcium 
intake in CD patients, which was then trialled on 50 patients. 
There were no significant differences between the population demographics for study 1 and study 2.  
65% of patients had a diagnosis of osteopenia or osteoporosis, in a female predominant population 
(74.6%).  Reported mean dietary calcium intake was over estimated at 1239.6mg/day (SD ± 377.1mg)
in study 1 and corrected to 852mg/day (SD ± 264.57mg) using improved methodology (study 2) 
(p≤0.05).  Understanding and compliance with dietary advice correlated positively with GFD (p≤0.001)
but not osteoporosis or fracture risk.  
Overall patients attending the clinic did not meet the BSG recommended calcium intake.  However, 
30% of patients could meet the 2014 BSG target from oral diet alone. Utilising individual dietary 
prescriptions and targeted use of calcium supplementation maximised the opportunity to reduce risk 
of bone disease and improved compliance with BSG recommendations.
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Introduction
Coeliac disease (CD) is a chronic autoimmune inflammatory condition of the small bowel generated 
by the ingestion of gluten in affected individuals [1] and characterised by atrophy of the villi in the 
small intestine due to enterocyte destruction.  This villous atrophy results in the suboptimal absorption
of micronutrients such as calcium, vitamin D, vitamin B12 and iron [2] and affects around 1 in 100 
people in the UK [3]. 
Risk of osteoporosis and associated bone loss conditions are elevated in CD patients [4, 5], resulting 
in an elevated fracture risk when compared to matched controls (hazard ratio 1.30) [6, 7]. Those 
patients experiencing gastrointestinal symptoms at diagnosis are also predisposed to lower bone 
mineral density (BMD), compared to non-symptomatic patients [4, 8].  
Adherence to a gluten free (GF) diet can lead to normalisation of BMD in children, but full 
normalisation of BMD is rarely observed in patients diagnosed as adults [7].   Increasing age and 
post-menopausal status also increases bone turnover and associated bone loss [9, 10]. The greatest 
improvements in adult BMD can be observed within the first year of adhering to a GF diet [9].
The diet of coeliac patients has a lower intake of vitamin D (p≤0.05) and calcium (p≤0.05), as well as 
energy and non-starch polysaccharide, when compared to dietary reference values and intake of the 
average UK population [11]. Dietary intakes significantly lower in vitamin D and calcium for CD 
patients potentially impact on bone remineralisation and therefore increases the risk of bone disease. 
This risk is recognised in the British Society of Gastroenterology (BSG) guidelines [1, 12] which 
recommend a dietary intake of 1000mg of calcium per day, with post-menopausal women and elderly 
men advised to consume a higher amount of 1200-1500mg per day.  In 2010, this was revised to 
1500mg per day [1], considerably higher than recommendations in other Western countries [13], and 
the UK recommended nutrient intake (RNI) for calcium in a general adult population (700 mg per day) 
[12]. Those patients identified as being deficient in dietary calcium should be offered calcium 
supplementation in line with BSG guidance [1, 14]. 
The risk of osteoporosis and low intake of relevant nutrients in the CD population suggests dietitians 
should consider optimising calcium intake, in addition to advising on a gluten free diet, for CD 
patients.  To undertake this successfully the dietitian must accurately assess dietary calcium intake 
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and monitor other bone disease risk factors such as menopausal status.  Standard dietetic 
assessment does not always facilitate this, therefore there is a need to standardise and improve 
calcium estimation to minimise the risk of bone disease in this population. 
The objective of this work was to evaluate the management of bone disease in a dietetic-led coeliac 
clinic to BSG guidelines [12, 14], with a secondary aim of designing an assessment tool to improve 
self-reported calcium intake estimation to assist clinical advice and intervention. 
Method
Study design 
The study was divided into two components.  Study 1 was a retrospective study analysing data 
collected to assess the current management of bone disease, with specific reference to calcium 
intakes, within the dietetic coeliac clinic with reference to BSG guidelines [12, 14]. All calcium intake 
estimations were recalculated using the calcium tool cited on the original dietetic record card 
(unknown reference source).  The investigator calculated these intakes to provide a consistent 
criterion measure.  
This evaluation highlighted key deficiencies in current practice, i.e. inaccurate calcium estimation, 
poor screening for fracture risk factors.  Therefore, a prospective study was designed to assess the 
efficacy of a new proforma specifically adapted to provide a focused tool to support dietetic 
management of bone disease.
This proforma was an updated version of the original record card (see materials supplement) and 
provided an improved method for estimating dietary calcium intakes.  The proforma also enabled the 
screening of symptoms, risk factors, dietary intake, compliance, degree of bone disease and 
medications prescribed, along with recording of patient demographics and documentation of advice.  
The proforma was then used to aid letter dictation and formed part of the patient’s medical record.  
This data was collected prospectively and the proforma was completed by the clinic dietitian.
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Table 1: illustration of key information collated by the new proforma
Additional information collated by the new
proforma to meet BSG guidance (12, 14)
Information adapted for inclusion from the
initial proforma that previously met BSG
guidance (12, 14)
Compliance with calcium supplements. Weight measured in kilograms (kg) by dietitian 
in clinic.
Accuracy of calcium intake estimations as 
measured using the calcium intake tool on 
proforma.
Height as reported by patient, recorded in 
metres (m).
Recording of menopausal state (females only). BMI calculated.
Recording of previous fractures reported by 
patient.
Weight change calculated by comparing the 
patient’s weight on previous clinic attendance to
the current weight.
Recording of patients reported vitamin D 
exposure.
Recording of medication prescribed.
Quantification of number of cigarettes/tobacco 
smoked per day.
Bone mineral density (BMD) classification 
measured using a DEXA scan and as classified 
by radiology department at UHA.
Quantification of number of units of alcohol 
consumed per day.
Recording of reported weight bearing exercise 
by dietitian.
All information as reported by the patient, unless stated otherwise.
Table 2: BSG guidelines [12, 14] for bone disease risk factors
Weight bearing exercise Smoking history
Menopausal status Bone fracture history
Alcohol intake Vitamin D exposure
All data as reported by patient.
Sampling and sample size
Retrospective study sample – all adult patients (18 years or over) who attended the dietetic-led 
coeliac annual review clinic between 1st January 2012 and 31st December 2012 (n = 229).  
Prospective study sample – adult patients (18 years or over) who attended the dietetic-led coeliac 
annual review clinic over an eight week period, between 5th December 2013 and 6th February 2014 (n 
= 50). 
As data was collected anonymously, therefore, it is not clear which, and how many participants, 
overlap between the two parts of the study. New patients are introduced to the clinic on a regular 
basis; some of the participants will be novel to the second part of the study only.  
Inclusion and exclusion criteria
All patients who attended the adult annual review coeliac clinic on the dates stated above were 
included in the study.  
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No direct exclusion criteria were applied.  However, due to the clinic requirements all patients newly 
diagnosed with CD or within the first three months post diagnosis were automatically excluded, as 
they attended the alternative clinic.
Ethical approval for the study was given by Life Sciences Faculty Research Ethics Committee 
University of Chester.
Statistical analysis
 A power calculation was performed in which a sample size of 50 was adequate in 95% of cases; 
therefore the retrospective sample size was also appropriate [15].
Data for study 1 were non-parametric and analysed using Chi-Squared tests, cross tabulation and/ or 
Fishers exact test (SPSS version 21). P<0.05 was accepted to denote statistical significance.
Data for study 2 were parametric analysed using two sample paired t-test, cross tabulation and Chi-
Squared test (SPSS version 21).  P<0.05 was accepted to denote statistical significance
Materials
Newly devised clinic proforma – see materials appendix.
Kirsty Martin 6
Results
Sample demographics
Table 3: Illustrates the sample demographics for studies 1 and 2
Sample demographics Study 1 Study 2
Gender Male 26.2% (n=60) 24.0% (n=12)
Female 73.8% (n=169) 76.0% (n=38)
Age at diagnosis Median 49.2 years 
(SD 17.4 years)
52.0 years
(SD 18.0 years)
Range 2 years– 87 years 7 – 88 years
BMI Median 26.7kg/m2
(SD 5.7kg/m2)
26.7kg/m2
(SD 6.3kg/m2)
Range 17-64kg/m2 19-50kg/m2
Sample demographics were comparable between studies (p=0.417; See Table 3). Median BMI of 
26.7kg/m2 (overweight) [16] was observed in both studies.  BMI ranged from 17kg/m2 (underweight) to
64kg/m2 (morbidly obese).
Study 1
Patients were reported to be compliant with the gluten free diet in 94% of cases in study 1(n=210).   
92% had a ‘good’ understanding of the gluten free (GF) diet.  Understanding of GF diet was positively 
correlated with compliance with the gluten free diet (p ≤ 0.001).    
65% of this coeliac population have been diagnosed with bone disease, osteopenia or osteoporosis, 
with 59% receiving medication (calcium and/or bisphosphonates) for this condition.  There was no 
correlation between osteoporosis and BMI (p=0.548). 
Table 4: Data for Calcium Intake
Dietary calcium intake Study 1 Study 2
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Mean  calcium intake 1239.6 mg/d
(SD 337.1mg/d)
852.0 mg/d *
(SD 264.6mg/d)
Greater than 1000 mg/d
Lower recommendation [1, 
12]
68% 30%
Greater than 1500 mg/d
Upper recommendation [12]
27% 4%
Greater than 1500 mg/d with 
supplementation
41% 69%
Less than 1000mg/d no 
supplementation
13% 18%
Calcium intake recorded on 
record card
70% 98%
Overall compliance with 
prescribed supplementation
Unable to assess 79%
Data are presented as mean (SD) where appropriate or as percentage of patients. * denotes a 
significant difference (p≤0.01).
Table 4 shows calcium intake for both study 1 and study 2. In study 1 68% of patients met the lower 
recommendation and 27% met the upper recommendation from dietary intake alone; this increased to
40% of patients with the use of supplements (see Table 4).  In 16.6% of cases patients were 
prescribed calcium supplements when their dietary intake was greater than 1500mg/day and, notably,
30% of patients had an intake of less than 1500mg/day and were not prescribed calcium 
supplementation; of these 13% of patients had a dietary intake below 1000mg/day.  The dietitian had 
recorded calcium intake as either adequate or inadequate in 70% of cases (Table 4). 
No significant association was found between DEXA scan results (indicating level of bone disease 
after Z score interpretation by radiologist) and estimated calcium intake of less than 1000mg/day 
(p=0.532) or less than 1500mg/day (p=0.112).  No significant association was found in the prevalence
of bone disease in those patients without calcium supplementation despite dietary calcium intake of 
less than 1000mg/day when compared to those with adequate intakes. 
On analysis, using ingredient breakdown provided by the product manufacturers and nutritional 
information tables [17], calcium intake in study 1 was found to be overestimated as values cited on 
record card were inaccurate.  Screening for bone disease risk factors, see table 2, and compliance 
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with calcium medication were also not screened for or prompted on record card. This led to the 
creation of the new record card utilised in study 2.
Study 2
59% of this coeliac population had been diagnosed with bone disease, osteopenia and osteoporosis, 
comparable to study 1 (65%, p = 0.518).
Study 1 Study 2
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Figur
e 1: percentage of patients receiving medication to reduce the risk of bone disease
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Fig
ure 2: reported compliance with medication in study 2
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Fig
ure 3: Compliance with medication by diagnosis of bone disease
Overall, reported compliance with medication was high (see figure 2).    However, 90% of patients 
with osteoporosis were compliant with calcium supplements compared to 71% with osteopenia and 33
% with normal bone densities (p≤0.05) (see figure 3).  
Ninety percent of patients reported compliance with a GF diet.  As shown in Table 4 mean dietary 
calcium intake in these patients, using the new tool, was 852mg/day (SD 264.6mg/d), significantly 
lower than study 1 (p<0.01).  When further analysing dietary calcium intake, fewer patients met the 
recommended intake of 1000mg/day or 1500mg of calcium per day from diet alone (27% and 4% 
respectively, Table 4). For patients prescribed supplements 69% had a total calcium intake of 
1000mg/ day or more, (Table 4).  In a small number of cases calcium supplements were prescribed 
when the dietary intake of calcium exceeded 1500mg/day (4%).  Notably 30.6% of patients had a 
dietary intake of less than 1500mg/day calcium and were not prescribed calcium supplementation; of 
these 18.4% had a dietary intake below the minimum recommended intake (1000mg/day; see Table 
4).  The dietitian had correctly recorded this deficiency in 90% of cases and advised these patients to 
increase their dietary calcium intake in 78% of cases. Assessment of dietary intake was completed in 
98% of cases in study 2.
No relationship was found between dietary intake of calcium and fracture rates.  No association was 
found between reported compliance with the gluten free diet and prevalence of bone disease in either 
study 1 or study 2. 
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Dietetic screening of risk factors associated with bone disease increased from 71.4% to 98% following
the implementation of the new dietary assessment tool.  The number of risk factors screened for also 
increased, along with calcium medication compliance.  Dietitians also reported positively on the new 
screening tool stating “the new proforma provides a more accurate and thorough calcium 
assessment” and “the new proforma was more thorough in terms of portions of calcium and bone 
disease risk factors”. 
Discussion 
Patients attending the dietetic-led coeliac service did not meet BSG guidance [1, 12, 14] for dietary 
calcium intake potentially impacting on effective long term management of bone disease in this 
population. Lack of compliance in the initial study is not clear due to inaccuracies in the calcium 
estimation values supplied by the record card. These inaccuracies meant dietary calcium intake was 
likely to be overestimated thus the true number of patients not meeting the recommended intakes was
potentially underestimated. According to Bianchi and Bardella [18] this would potentially increase the 
risk of low BMD and osteoporotic fracture in the long term, however the current study did not find a 
correlation between calcium intake and bone fracture risk.  In common with Fouda et al. [13] and 
Thompson et al. [19] suboptimal calcium intakes were observed, 886±332mg/d and 884.7±371.8mg/d 
respectively. As this is cross sectional data the long term impact of poor calcium intake needs further 
investigation.
These investigations demonstrated that, with dietetic support,  30% of patients can meet the current 
BSG recommended daily calcium intake of 1000 mg/d from diet alone, even when utilising a more 
accurate method of calculating dietary calcium intake (as in study 2). In fact 4% of patients meet the 
2010 guidance recommendation of 1500 mg/d from dietary intake alone, using the estimation method 
trialled in study 2. 
In this CD population the targeting of prescription of calcium and bisphosphonate supplements to 
those who need it could be improved as 18% of patients not achieving 1000mg/d calcium intake from 
their diet were not prescribed a supplement. Equally noteworthy when considering effective targeting 
of prescription is the fact that 17% of patients were prescribed supplements although their calcium 
intake exceeded 1500 mg/day. This suggests that the first level dietetic intervention could focus on 
increasing calcium intake from dietary sources, with a second level of intervention targeted on 
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prescribing calcium supplements to those whose calcium intake remains poor after the first line 
intervention has been completed.
Reported compliance with supplementation was 77% for the study population, reflecting the 
prevalence of bone disease within this CD population (59% of patients). Those with a diagnosis of 
osteoporosis were more likely to be compliant; compliance in patients with no current diagnosis of 
bone disease was only 33% suggesting the presence of bone disease improves motivation more than 
prevention of bone disease in this population. Those with a diagnosis of bone disease were more 
likely to be prescribed supplements. 
The compliance rates with prescribed supplements and GF diet reported in this study were high in 
comparison to other studies.  This may be a product of the self-reported nature of the data; Leffler et 
al. [20] found adherence to a GF diet to be over reported in a CD population, with 70% of participants 
reporting strict adherence, compared with 50% when dietary adherence was assessed by a trained 
clinician.  In a female population; Cramer et al. [21] reported compliance rates as low as 57.6% with 
bisphosphonate therapy, which further reduced to 31.7% twelve months post initial prescription in 
post-menopausal women, 87.5% compliance with calcium supplements was reported in the 
menopausal patients. Fouda et al. [13] also found both dietary histories and food diaries reported by 
the patients were inaccurate, subject to reporter bias; this emphasises the need for interpretation by a 
trained professional who is able to recognise and explore inaccuracies to improve the quality of 
information recorded and suggests compliance with a gluten free diet and prescribed supplements 
needs further study to ascertain actual intake.
Conclusion
The data from this study supports the role for dietetic led clinics to monitor and evaluate the status of 
CD patients. This monitoring includes consideration of risk for bone disease and the use of 
individualised dietary prescriptions that not only promote compliance with GF dietary advice but also 
advice on dietary measures to address other nutritional concerns, such as low dietary calcium intake. 
With appropriate support many patients can meet guideline recommendations for calcium via oral 
intake alone and adhere to a gluten free diet. Where the patient is unable to meet recommended 
intakes, or other risk factors are present, accurate information gathering and record keeping can 
support appropriate targeting for further treatments such as calcium supplementation prescription.  In 
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cases where calcium and vitamin D deficiencies are identified a combined supplement may be 
required. 
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MaterialsCOELIAC DISEASE CLINIC PROFORMA
MEDICAL
Weight:  …………….kg Height: …………….m BMI: …………….kg/m2 Weight loss: ……………..%
Date of diagnosis: …………………………………………………………………
Symptoms prior to diagnosis: ………………………………………………. Symptoms 
resolved: Yes No
Family history:CD T1DM IBD Flu jab
Bowel habit: Normal Diarrhoea Blood Constipation
New symptoms:   Appetite Lethargy Rash Other       
N/AMedication: Ca2+ supplements            Date started: ……………………   Compliant:  Yes       
No 
Bisphosphonates            Iron    B12Other medication (please list): 
…………………………………………………………………………………………………………
Bloods requested: Yes No RefusedFirst DEXA scan date: …………
Result: Normal Osteopenia     Osteoporosis
Last DEXA scan date: ………… Result: Normal Osteopenia     Osteoporosis
DEXA scan requested:Yes  Not required Info for first DEXA not availableDIETARY
Gluten consumed: Never             Occasionally     Accidentally        Frequently
Checking labels: Yes No
Prescribed products: Yes No Quantity: ………………………..
Prepayment certificated:    Yes     No Coeliac UK member: Yes    
No
Cross contamination:   Separate toaster Separated butter
BONE DISEASE RISK FACTORS
Weight bearing exercise: Yes No Previous fractures: Yes     
No
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Post menopause:                 Yes No N/A Vitamin D exposure: Yes     
No
Alcohol (drinks/day): 0 1-2 3-4   5-6   7-9     9+
Smoking (cigarettes/day): 0 1-5 6-10 11-15     16-20          21-30
31+Comments/outcome:
………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………
…………………………………………………………………….
Materials Continued
DIET HISTORY ASSESSMENT 
Compliant: Yes    No
Morning 250mg Ca2+ per portion:
200ml semi/skimmed milk
200ml ca2+ fortified soya milk
150g yoghurt
30g/matchbox cheese
4 small sardines with bones
200g/1/2 tin custard/rice pud
50g/2xmatchboxes plain tofu
150g dried figs
50mg Ca2+ per portion:
2tbs fromage frais
1 orange
100g green vegetables
100g baked beans
25g milk chocolate
2tbs cottage cheese
2xslices GF white bread
Total/day:
Advised to increase:
Mid morning
Lunch Iron containing foods:
90g red meat – 3mg
100g liver – 11mg
80mg dried figs/apricots – 3mg
2tbs cashew nuts – 1.5mg
90g spring greens/lentils – 1mg
Total/day:
Advised to increase:
Advised on Vitamin C:
Mid afternoon CHO
Portions/day:
High fibre:
Evening Protein
Portions/day:
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Fruit
Portion /day:
Vegetables
Portions/day:
Supper/late evening High fat/sugar
Biscuits
Cakes
Crisp
Chocolate
Takeaways
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